Profil
An Song currently works at 4D Molecular Therapeutics, Inc., as Chief Research & Translational Development Officer from 2024.
Dr. Song also formerly worked at Immune-Onc Therapeutics, Inc., as Chief Scientific Officer.
Dr. Song received her doctorate degree from Indiana University.
Aktive Positionen von An Song
| Unternehmen | Position | Beginn |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 25.09.2024 |
Ehemalige bekannte Positionen von An Song
| Unternehmen | Position | Ende |
|---|---|---|
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company advancing novel therapies that target myeloid cells | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2021 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01.07.2018 |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.08.2002 |
Ausbildung von An Song
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company advancing novel therapies that target myeloid cells | Health Technology |
















